Tiziana Life Sciences Ltd. (Bermuda) (TLSA)
0.9897
-0.03
(-2.97%)
USD |
NASDAQ |
Sep 08, 16:00
0.9885
0.00 (0.00%)
Pre-Market: 20:00
Tiziana Life Sciences Market Cap : 119.27M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 119.27M |
| September 04, 2026 | 122.92M |
| September 03, 2026 | 117.43M |
| September 02, 2026 | 112.25M |
| September 01, 2026 | 116.12M |
| August 31, 2026 | 119.06M |
| August 28, 2026 | 121.71M |
| August 27, 2026 | 130.15M |
| August 26, 2026 | 131.35M |
| August 25, 2026 | 133.76M |
| August 24, 2026 | 138.58M |
| August 21, 2026 | 137.38M |
| August 20, 2026 | 134.97M |
| August 19, 2026 | 128.94M |
| August 18, 2026 | 134.97M |
| August 17, 2026 | 138.58M |
| August 14, 2026 | 136.78M |
| August 13, 2026 | 125.33M |
| August 12, 2026 | 119.30M |
| August 11, 2026 | 121.71M |
| August 10, 2026 | 121.71M |
| August 07, 2026 | 120.51M |
| August 06, 2026 | 117.41M |
| August 05, 2026 | 119.30M |
| August 04, 2026 | 116.60M |
| Date | Value |
|---|---|
| August 03, 2026 | 116.81M |
| July 31, 2026 | 124.12M |
| July 30, 2026 | 116.89M |
| July 29, 2026 | 115.54M |
| July 28, 2026 | 116.55M |
| July 27, 2026 | 109.69M |
| July 24, 2026 | 107.55M |
| July 23, 2026 | 122.92M |
| July 22, 2026 | 113.88M |
| July 21, 2026 | 120.51M |
| July 20, 2026 | 122.32M |
| July 17, 2026 | 128.94M |
| July 16, 2026 | 132.56M |
| July 15, 2026 | 133.76M |
| July 14, 2026 | 149.43M |
| July 13, 2026 | 160.27M |
| July 10, 2026 | 148.22M |
| July 09, 2026 | 151.84M |
| July 08, 2026 | 150.63M |
| July 07, 2026 | 151.84M |
| July 06, 2026 | 140.99M |
| July 02, 2026 | 157.86M |
| July 01, 2026 | 148.22M |
| June 30, 2026 | 154.25M |
| June 29, 2026 | 148.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alkermes Plc | 7.621B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Amarin Corp. Plc | 299.28M |
| Anika Therapeutics, Inc. | 281.58M |
Market Cap Related Metrics
| Price | 0.9897 |
| Earnings Yield | -15.74% |